 |
VOOZH | about |
|
VOOZH | about |
*606423
Table of Contents
HGNC Approved Gene Symbol: DIRC1
Cytogenetic location: 2q32.2 Genomic coordinates (GRCh38) : 2:188,733,738-188,790,123 (from NCBI)
Podolski et al. (2001) described a reciprocal, balanced, constitutional chromosome translocation, t(2;3)(q33;q21), that is associated with familial clear cell renal cancer (144700). By standard positional cloning strategies, Druck et al. (2001) isolated a gene disrupted by the chromosome 2 breakpoint. The gene, designated DIRC1 (disrupted in renal cancer-1), was disrupted between exons 1 and 2 by the familial translocation. The 1.5-kb DIRC1 mRNA encoded an 11-kD predicted protein of 104 amino acids. RT-PCR analysis detected low-level expression of DIRC1 in adult placenta, testis, ovary, and prostate, and in fetal kidney, spleen, and skeletal muscle. Two familial tumors showed loss of the derivative chromosome 3, as observed in a Dutch kindred with t(2;3)-associated renal cancers in a Dutch family. Druck et al. (2001) concluded that further studies were necessary to determine if inactivation of the DIRC1 gene contributes to the development of familial cancers.
Druck et al. (2001) determined that the DIRC1 gene contains 2 exons and spans approximately 57 kb of genomic DNA.
By positional cloning, Druck et al. (2001) mapped the DIRC1 gene to chromosome 2q33.
Druck, T., Podolski, J., Byrski, T., Wyrwicz, L., Zajaczek, S., Kata, G., Borowka, A., Lubinski, J., Huebner, K. The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J. Hum. Genet. 46: 583-589, 2001. [PubMed: 11587072, related citations] [Full Text]
Podolski, J., Byrski, T., Zajaczek, S., Druck, T., Zimonjic, D. B., Popescu, N. C., Kata, G., Borowka, A., Gronwald, J., Lubinski, J., Huebner, K. Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J. Hum. Genet. 46: 685-693, 2001. [PubMed: 11776380, related citations] [Full Text]
HGNC Approved Gene Symbol: DIRC1
Cytogenetic location: 2q32.2 Genomic coordinates (GRCh38) : 2:188,733,738-188,790,123 (from NCBI)
Podolski et al. (2001) described a reciprocal, balanced, constitutional chromosome translocation, t(2;3)(q33;q21), that is associated with familial clear cell renal cancer (144700). By standard positional cloning strategies, Druck et al. (2001) isolated a gene disrupted by the chromosome 2 breakpoint. The gene, designated DIRC1 (disrupted in renal cancer-1), was disrupted between exons 1 and 2 by the familial translocation. The 1.5-kb DIRC1 mRNA encoded an 11-kD predicted protein of 104 amino acids. RT-PCR analysis detected low-level expression of DIRC1 in adult placenta, testis, ovary, and prostate, and in fetal kidney, spleen, and skeletal muscle. Two familial tumors showed loss of the derivative chromosome 3, as observed in a Dutch kindred with t(2;3)-associated renal cancers in a Dutch family. Druck et al. (2001) concluded that further studies were necessary to determine if inactivation of the DIRC1 gene contributes to the development of familial cancers.
Druck et al. (2001) determined that the DIRC1 gene contains 2 exons and spans approximately 57 kb of genomic DNA.
By positional cloning, Druck et al. (2001) mapped the DIRC1 gene to chromosome 2q33.
Druck, T., Podolski, J., Byrski, T., Wyrwicz, L., Zajaczek, S., Kata, G., Borowka, A., Lubinski, J., Huebner, K. The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J. Hum. Genet. 46: 583-589, 2001. [PubMed: 11587072] [Full Text: https://doi.org/10.1007/s100380170025]
Podolski, J., Byrski, T., Zajaczek, S., Druck, T., Zimonjic, D. B., Popescu, N. C., Kata, G., Borowka, A., Gronwald, J., Lubinski, J., Huebner, K. Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation. J. Hum. Genet. 46: 685-693, 2001. [PubMed: 11776380] [Full Text: https://doi.org/10.1007/s100380170001]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM